Palliativtherapie beim Ösophaguskarzinom

Zusammenfassung

Hintergrund: Die Palliativtherapie von Patienten mit inkurablem Ösophaguskarzinom erfordert ein breites Spektrum unterschiedlicher Maßnahmen zur Linderung der Beschwerden. Methoden: Operative Verfahren (palliative Tumorresektion, Bypass-Verfahren) sind infolge der hohen Letalität nur noch selten indiziert. Im Vordergrund stehen neben allgemeinen Palliativmaßnahmen symptomorientierte Verfahren zur Beseitigung der Dysphagie und Sicherstellung der Nahrungsaufnahme, insbesondere der endoskopisch oder radiologisch eingebrachte Stent, bei Versagen die Ernährungssonde und tumorspezifische Maßnahmen (Brachytherapie, Radiochemotherapie, Chemotherapie). Diskussion: Die Wahl richtet sich nach den Beschwerden, der Tumorsituation, dem Allgemeinzustand und den Wünschen des Patienten. Nach Möglichkeit sollte für jeden Patienten ein individuelles Behandlungskonzept interdisziplinär erstellt und abhängig vom Krankheitsverlauf modifiziert werden. Schlussfolgerung: Aufgabe künftiger Studien wird es sein, die optimale Kombination einer rein symptomatischen Behandlung mit tumorspezifischen Maßnahmen unter dem Aspekt der erreichbaren Lebensqualität zu klären.

Abstract

Background: Palliative therapy for patients with incurable oesophageal cancer necessitates a broad spectrum of different measures to relieve symptoms. Methods: Surgical procedures (palliative tumour resections, bypass surgery) are rarely indicated on account of the high morbidity. Preeminent treatment options to eliminate dysphagia and to ensure food passage are endoscopic procedures, in particular, the endoscopically or radiologically guided stent implantation. In case of failure, a percutaneous feeding tube and general palliative measures are required. Furthermore tumour-specific therapies (brachytherapy, radiochemotherapy, chemotherapy) are applied. Discussion: The choice of the procedure is based on the symptoms, the tumour situation, the patients’ general status, and their preferences. If possible, an individual, interdisciplinary treatment concept for each patient should be designed and modified according to the course of the disease. Conclusions: It should be the aim of future studies to elucidate the optimal combination of a merely symptomatic treatment with tumour-specific measures under the aspect of the achievable quality of life.

Ösophaguskarzinom - Palliativtherapie - Dysphagie - Stent - Radiochemotherapie

oesophageal carcinoma - palliative therapy - dysphagia - stent - radiochemotherapy

Literatur

• 1 Stavraou E P, Smith G S, Baker D F. Surgical outcomes associated with oesophagectomy in New South Wales: an investigation of hospital volume.  J Gastrointest Surg. 2010;  14 951-957
• 2 McKian K P, Miller R C, Cassivi S D et al. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy.  Dis Esophagus. 2006;  19 448-453
• 3 Frenken M. Best palliation in esophageal cancer: surgery, stenting, radiation or what?.  Dis Esophagus. 2001;  14 120-123
• 4 Burstow M, Kelly T, Panchani S et al. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.  Dis Esophagus. 2009;  22 519-525
• 5 Siersema P D. New developments in palliative therapy.  Best Pract Res Clin Gastroenterol. 2006;  20 959-978
• 6 Lazaraki G, Katsinelos P, Nakos A et al. Malignant esophageal dysphagia palliation using insertion of a covered Ultraflex stent without fluoroscopy: a prospective observational study.  Surg Endosc. 2010;  [Epub ahead of print]
• 7 Siersema P D, Hop W C, van Blankenstein M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study.  Gastrointest Endosc. 2001;  54 145-153
• 8 Sgourakis G, Gockel I, Radtke A et al. The use of self-expanding stents in esophageal and gastroesophageal junction cancer palliation: A meta-analysis and meta-regression analysis of outcomes.  Dig Dis Sci. 2010;  55 3018-3030
• 9 Eickhoff A, Jakobs R, Riemann J F. Palliative treatment options for esophageal and gastric cancer.  Internist. 2004;  45 756-768
• 10 Sreedharan A, Harris K, Crellin A et al. Interventions for dysphagia in oesophageal cancer.  Cochrane Database Syst Rev. 2009;  7 CD005048
• 11 Meunier B, Spiliopoulos Y, Stasik C et al. Retrosternal bypass operation for unresectable squamous cell cancer of the esophagus.  Ann Thorac Surg. 1996;  62 373-377
• 12 Koike R, Nishimura Y, Nakamatsu K et al. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.  Int J Radiat Oncol Biol Phys. 2008;  70 1418-1422
• 13 Binkert C A, Petersen B D. Two fatal complications after parallel tracheal-esophageal stenting.  Cardiovasc Intervent Radiol. 2002;  25 144-147
• 14 Herth F J, Peter S, Baty F et al. Combined airway and esophageal stenting in malignant airway esophageal fistulas: a prospective study.  Eur Respir J. 2010;  [Epub ahead of print]
• 15 Schmidberger H, Hess F, Becker H et al. Ösophagus. In: Bamberg M, Molls M, Sack H, Hrsg. Radioonkologie. 2. Aufl. Band 2. München: Zuckschwerdt; 2009: 317–344
• 16 Cooper J S, Matthew D G, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85–01).  JAMA. 1999;  281 1623-1627
• 17 Wong R K, Malthaner R A, Zuraw L et al. Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline.  Int J Radiat Oncol Biol Phys. 2003;  55 930-942
• 18 Homs M Y, Steyerberg E W, Eijkenboom W M et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.  Lancet. 2004;  364 1497-1504
• 19 Sur R K, Donde B, Levin V C et al. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.  Int J Radiat Oncol Biol Phys. 1998;  40 447-453
• 20 Taal B G, Aleman B M, Koning C C et al. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.  Br J Cancer. 1996;  74 1452-1457
• 21 Wong S KH, Chiu P WJ, Leung S F et al. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus. A case-controll study.  Ann Surg Oncol. 2008;  15 576-582
• 22 Font A, Arellano A, Fernández-Llamazares J et al. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer.  Clin Transl Oncol. 2007;  9 177-182
• 23 Wobbes T, Baron B, Paillot B et al. Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus.  Eur J Cancer. 2001;  37 470-477
• 24 Ruhstaller T, Templeton A, Ribi K et al. Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76 / 02).  Onkologie. 2010;  33 222-228
• 25 Crosby T D, Brewster A E, Borley A et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma.  Br J Cancer. 2004;  90 70-75
• 26 Müller J M, Erasmi H, Zieren U et al. Die palliativ-chirurgische Behandlung des Karzinoms der Speiseröhre.  Med Klinik. 1991;  86 24-31
• 27 DiFranco F, Lamb R J, Karat D et al. Iatrogenic perforation of localized oesophageal cancer.  Brit J Surg. 2008;  95 837-839
• 28 Enzinger P C, Ilson D H, Kelsen D P. Chemotherapy in esophageal cancer.  Semin Oncol. 1999;  26 (5 Suppl 15) 12-20
• 29 Grünberger B, Raderer M, Schmidinger M et al. Palliative chemotherapy for recurrent and metastatic esophageal cancer.  Anticancer Res. 2007;  27 2705-2714
• 30 Al-Batran S E, Ajani J A. Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer.  Cancer. 2010;  116 2511-2518
• 31 Loizou L A, Rampton D, Atkinson M et al. A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia.  Cancer. 1992;  70 386-391
• 32 Gillison E W, Powell J, McConkey C C et al. Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia.  Br J Surg. 2002;  89 344-348
• 33 Gockel I, Kneist W, Junginger T. Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.  World J Surg. 2006;  30 183-190